October 25, 2014

NEA.BPD Blog  TwitterTwitter

Research Across the Lifespan and Clinical Applications for Treatment – October 18-19, 2008

Presented by:

National Education Alliance for Borderline Personality Disorder, and Department of Psychiatry, University of Minnesota, Medical School

This conference is specifically designed to offer those persons whose lives are impacted by Borderline Personality Disorder (BPD), professionals, relatives, and consumers, a forum to better understand this complex disorder from various perspectives. An internationally recognized faculty will present up-to-date information on key issues pertaining to many aspects of the disorder. We will cover diagnosis and treatments across the life span, co-occurring disorders and medical issues, personal and social impact, new research, self-injury and suicide, longitudinal perspectives and current research, medications, and consumer/family perspectives.

Statement of Need

Borderline Personality Disorder (BPD) is a serious mental illness characterized by pervasive instability in moods, interpersonal relationships, self-image, and behavior. This instability often disrupts family and work life, long-term planning, and the individual’s sense of self-identity. While less known than schizophrenia or bipolar disorder (manic-depressive illness), BPD is more common, affecting 5.9% of adults. This conference is intended to bring the latest in education to both clinicians and family members.

Audience

This conference would be ideal for psychiatrists, psychologists, nurses, social workers and family members whose lives are impacted by Borderline Personality Disorder.

Educational Objectives

Following this conference, participants should be able to:

  • Identify age-associated variations in BPD
  • Distinguish between developmental issues and BPD
  • Outline skills potentially effective to modify maladaptive adolescent behavior
  • Delineate high-risk factors for suicidal behavior and implement a high-risk assessment
  • Specify pharmacological treatments for all age ranges and their risk/benefit ratios
  • Interpret the interpersonal difficulties of patients in the context of attachment issues
  •  Identify family skills based on the principles of DBT

Disclosure Policy

It is the policy of the University of Minnesota Office Of Continuing Medical Education to ensure balance, independence, objectivity and scientific rigor in all of its sponsored educational activities. All participating faculty, course directors, and planning committee members are required to disclose to the program audience any financial relationships related to the subject matter of this program. It is not necessary to disclose relationships with non-profit or government organizations or proprietary entities that do not produce health care goods or services. Relationships of spouse/partner with proprietary entities producing health care goods or services should be disclosed if they are of a nature that may influence the objectivity of the individual in a position to control the content of the CME activity. Disclosure information is reviewed in advance in order to manage and resolve any possible conflicts of interest. Specific disclosure information for each course faculty will be shared with the audience prior to the faculty’s presentation.

Support

At the time of printing, this conference is supported in part by an unrestricted NIMH educational grant: 1R13MH081768-01 Translating Research into Practice. All participating organizations will be acknowledged in the final program.

Conference Program

Overview: International Perspectives Mary C. Zanarini, EdD Go to Video Listen to Audio
Overview: International Perspectives Anthony Bateman, MD Go to Video Listen to Audio
Red Flags in Childhood: Early Markers for BPD Nicki R. Crick, PhD Go to Video Listen to Audio
Adolescence or BPD: How to Tell the Difference Alec L. Miller, PsyD Go to Video Listen to Audio
Interpersonal Relationships: Where Does Attachment Fit In Anthony W. Bateman, MD Go to Video Listen to Audio
Suicidal Behavior and Self Injury: Applications of Research to Clinical Practice Barbara Stanley, PhD Go to Video Listen to Audio
What to Medicate and When: the Role of Medication Across the Ages Kenneth R. Silk, MD Go to Video Listen to Audio
Understanding Validation in Families Alan E. Fruzzetti, PhD Go to Video Listen to Audio
Genetics and Borderline Personality Disorder Scott Wilson, Ph.D. Go to Video Listen to Audio
Following Symptoms and Their Developmental Course Over Two Decades: Where Does It Go? Patricia Cohen, PhD Go to Video Listen to Audio
Ten-year Course: Longitudinal Study Mary Zanarini, EdD Go to Video Listen to Audio
Interpersonal Hypersensitivity: Origins and Implications John G. Gunderson, MD Go to Video Listen to Audio

 

COURSE FACULTY

ANTHONY W. BATEMAN, MA, MD, FRCPsych
Consultant Psychiatrist in Psychotherapy, Halliwick Unit, St. Ann’s Hospital, London;
Visiting Professor, University College, London, England;
Visiting Consultant, Menninger Clinic, Baylor College of Medicine, Houston, TX

PATRICIA COHEN, PhD
Professor of Clinical Public Health (Epidemiology) in Psychiatry, Columbia University;
Principal Research Scientist, Department of Epidemiology of Mental Disorders, New York State Psychiatric Institute, New York, NY

NICKI R. CRICK, PhD
Professor of Clinical Psychology; Director of the Institute of Child Development;
Director of the Center on Relational Aggression, University of Minnesota, Minneapolis, MN;
Co-Course Director

ALAN E. FRUZZETTI, PhD
Associate Professor Psychology; Director, Dialectical Behavior Therapy and Research Program, University of Nevada, Reno, Nevada; Director of Research, National Education Alliance for Borderline Personality Disorder, Rye, NY

JOHN G. GUNDERSON, MD
Professor of Psychiatry, Harvard Medical School;
Director, Center for Treatment and Research on Borderline Personality Disorder, McLean Hospital, Belmont, MA

PERRY D. HOFFMAN, PhD
President, National Education Alliance for Borderline Personality Disorder, Rye, NY;
Co-Course Director

ALEC L. MILLER, PsyD
Associate Professor of Psychiatry and Behavioral Sciences;
Chief, Child and Adolescent Psychology, Montefiore Medical Center, Albert Einstein College of Medicine of Yeshiva University, Bronx, NY

RICHELLE MOEN-MOORE, PhD
Assistant Professor, Department of Psychiatry, University of Minnesota Medical School, Minneapolis, MN;
Co-Course Director

KENNETH R. SILK, MD
Professor, Department of Psychiatry, University of Michigan Medical School; Director, Personality Disorders Program, Ann Arbor, MI; Science Editor, BPDForum, National Education Alliance for Borderline Personality Disorder, Rye, NY

BARBARA H. STANLEY, PhD
Research Scientist, Professor, Department of Psychiatry, Columbia University College of Physicians & Surgeons;
Research Scientist and Director, Suicide Intervention Center, New York State Psychiatric Institute, New York, NY

MARY C. ZANARINI, EdD
Professor of Psychology, Harvard Medical School;
Director, Laboratory for the Study of Adult Development, McLean Hospital, Belmont, MA

PLANNING COMMITTEE

PERRY D. HOFFMAN, PhD
President, National Education Alliance for Borderline Personality Disorder, Rye, NY

S. CHARLES SCHULZ, MD
Professor and Head, Department of Psychiatry, University of Minnesota Medical School, Minneapolis, MN

PATRICIA WOODWARD, MAT
Secretary/Treasurer, National Education Alliance for Borderline Personality Disorder, Rye, NY